Mark William Lowdell - May 14, 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Scientific Officer, 10%+ Owner
Signature
/s/ Mark William Lowdell
Stock symbol
INMB
Transactions as of
May 14, 2024
Transactions value $
$0
Form type
4
Date filed
5/16/2024, 04:08 PM
Previous filing
Apr 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +100K $0.00 100K May 14, 2024 Common Stock 100K $9.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date.